Health specialists are calling for a fundamental shift in the clinical approach to treating anaemia, warning that the common practice of treating the condition as a monolithic ailment—often through generic iron supplementation—can be ineffective and potentially harmful. During a recent professional medical session, experts emphasized that anaemia is a symptom of various underlying pathologies rather than a standalone disease, necessitating a diagnostic framework that prioritizes the identification of the root cause before initiating treatment.
The core of the medical community’s concern lies in the tendency to prescribe iron supplements as a first-line response to low hemoglobin levels without comprehensive screening. While iron deficiency is a frequent cause of anaemia, specialists noted that treating all patients with iron ignores other critical possibilities, such as vitamin deficiencies, chronic diseases, genetic blood disorders, or internal hemorrhaging. By focusing on the symptom (low hemoglobin) rather than the cause, clinicians risk masking serious underlying health issues that require specific, non-iron-based interventions.
According to the experts, the path to effective recovery is contingent upon a targeted diagnostic process. This involves a rigorous screening phase to determine whether the anaemia is caused by a lack of iron, a deficiency in B12 or folate, bone marrow failure, or the destruction of red blood cells (hemolysis). A targeted approach ensures that patients receive medical interventions tailored to their specific biological needs, reducing the time to recovery and preventing the complications associated with incorrect medication.
Analysis:
The push for diagnostic precision represents a direct critique of current clinical trends where iron deficiency is often presumed by default. This “presumptive treatment” model is frequently driven by the prevalence of iron deficiency in certain populations, but it creates a systemic blind spot for non-iron-deficiency anaemias. By advocating for the identification of the “underlying cause,” medical professionals are pushing for a move away from symptomatic management toward a systemic diagnostic framework.
This shift is critical because unnecessary iron supplementation can be counterproductive. In cases of certain types of anaemia or underlying conditions like hemochromatosis, adding more iron to the system can lead to iron overload, which may damage the liver, heart, and endocrine system. Therefore, the experts’ insistence on early and accurate diagnosis is not merely a matter of efficiency, but a necessary safety measure to prevent iatrogenic harm—injury caused by medical treatment.
The context of this debate is rooted in the global burden of anaemia, which affects millions of people across diverse demographics. In many regions, public health initiatives have focused heavily on mass iron fortification and supplementation programs to combat malnutrition. While these programs have addressed widespread iron deficiency, they have occasionally overshadowed the need for individual clinical diagnosis. The current call from experts suggests a need to balance broad public health interventions with individualized clinical rigor.
Furthermore, the complexity of anaemia means that it often co-exists with other chronic conditions. For instance, anaemia of chronic disease occurs when an underlying infection or inflammatory condition interferes with the body’s ability to use iron, even if iron stores are adequate. In such cases, treating the anaemia with iron supplements will not resolve the issue; instead, the primary inflammatory condition must be treated. This reinforces the experts’ argument that anaemia must be viewed as a signal of a deeper systemic failure rather than a simple nutrient deficit.
Looking forward, the medical community is watching for a broader adoption of comprehensive screening protocols in primary care settings. The goal is to integrate more sophisticated blood tests—such as ferritin levels, serum iron, and total iron-binding capacity (TIBC)—into the initial diagnostic phase rather than as secondary tests. There is also an increasing focus on the role of nutritionists and hematologists working in tandem to ensure that dietary interventions are based on verified deficiencies rather than general assumptions.
The success of this shift will depend on the willingness of healthcare providers to move away from “one-size-fits-all” prescriptions. This may require updated clinical guidelines and better training for general practitioners to recognize the red flags of non-iron-deficiency anaemia. As diagnostic tools become more accessible, the expectation is that the medical field will transition toward a “diagnose-first, treat-second” model.
In conclusion, the consensus among these health experts is that the current approach to anaemia treatment requires an urgent evolution. By prioritizing early diagnosis and the rigorous identification of underlying causes, the medical community can move toward a more precise, safe, and effective standard of care. Shifting the focus from the symptom of low hemoglobin to the biological driver of the condition is the only way to ensure that patients receive the correct treatment and that life-threatening underlying causes are not overlooked.
Sources:
The Hindu – National: https://www.thehindu.com/sci-tech/health/experts-stress-early-diagnosis-and-identifying-underlying-cause-of-anaemia/article71269138.ece
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: The Hindu – National — source
